Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials for Cancer in United States

6986 results

Sort By:

Selinexor and Backbone Treatments of Multiple Myeloma Patients

Study ID: NCT02343042
Start Date: 2015-10
End Date: 2027-04
Study Type

Interventional

Study Phase

Phase2

No. of Participants

300

Intervention / Treatment

Selinexor

Dexamethasone

Lenalidomide

Pomalidomide

Bortezomib

daratumumab

Carfilzomib

Ikhazomiv

Elotuzumab

Clarithromycin

Belantamab Mafodotin

Mezigdomide

Sponsor

Karyopharm Therapeutics Inc

Source: clinicaltrials.gov

Share:
Add to list

A Study of Short-Course Radiation Therapy With Chemotherapy in People With Endometrial Cancer

Study ID: NCT05691010
Start Date: 2023-01-10
End Date: 2026-01-10
Study Type

Interventional

Study Phase

Early_phase1

No. of Participants

28

Intervention / Treatment

Intensity-modulated radiation therapy

Carboplatin

Paclitaxel

Sponsor

Memorial Sloan Kettering Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

SBRT +/- Pembrolizumab in Patients With Local-Regionally Recurrent or Second Primary Head and Neck Carcinoma

Study ID: NCT03546582
Start Date: 2018-11-14
End Date: 2029-07
Study Type

Interventional

Study Phase

Phase2

No. of Participants

102

Intervention / Treatment

Pembrolizumab

Stereotactic Body Radiation Therapy (SBRT)

Sponsor

RTOG Foundation, Inc.

Source: clinicaltrials.gov

Share:
Add to list

Genomic Risk in Retroperitoneal Sarcoma

Study ID: NCT06436846
Start Date: 2022-03-07
End Date: 2027-08-01
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

50

Intervention / Treatment

Biospecimen sample collection during standard-of-care surgery

Sponsor

Fox Chase Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors

Study ID: NCT03067181
Start Date: 2017-05-25
End Date: 2027-06-30
Study Type

Interventional

Study Phase

Phase3

No. of Participants

1780

Intervention / Treatment

Best Practice

Biopsy Procedure

Biospecimen Collection

Bleomycin Sulfate

Carboplatin

Cisplatin

Computed Tomography

Etoposide

Magnetic Resonance Imaging

Pharmacogenomic Study

Pulmonary Function Test

Quality-of-Life Assessment

Administration Questionnaire

Sponsor

Children's Oncology Group

Source: clinicaltrials.gov

Share:
Add to list

Exercise in Prostate Cancer

Study ID: NCT06165302
Start Date: 2025-10-16
End Date: 2030-01-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

20

Intervention / Treatment

Exercise Intervention

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Source: clinicaltrials.gov

Share:
Add to list

A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM) or Monoclonal Gammopathy of Undetermined Significance (MGUS)

Study ID: NCT06055894
Start Date: 2023-09-20
End Date: 2026-09
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

200

Intervention / Treatment

Omega-3

Curcumin

Probiotic

Whole food, plant-based diet (WFPBD)

Sponsor

Memorial Sloan Kettering Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

A Study Evaluating the Safety, Pharmacokinetics, and Activity of RO7656594 In Participants With Advanced or Metastatic Prostate Cancer

Study ID: NCT05800665
Start Date: 2023-05-02
End Date: 2027-06-30
Study Type

Interventional

Study Phase

Phase1

No. of Participants

210

Intervention / Treatment

Go to plan4

Sponsor

Genentech, Inc.

Source: clinicaltrials.gov

Share:
Add to list

Acalabrutinib and Venetoclax With or Without Early Obinutuzumab for the Treatment of High Risk, Recurrent, or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Study ID: NCT04169737
Start Date: 2020-07-29
End Date: 2026-07-09
Study Type

Interventional

Study Phase

Phase2

No. of Participants

168

Intervention / Treatment

Acalabrutinib

Obinutuzumab

Venetoclax

Sponsor

M.D. Anderson Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Evaluation of Stool Based Markers for the Early Detection of Colorectal Cancers and Adenomas

Study ID: NCT00843375
Start Date: 2019-08-07
End Date: 2028-03
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

1200

Intervention / Treatment
Sponsor

University of Michigan Rogel Cancer Center

Source: clinicaltrials.gov

Share:
Add to list